Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yeying Liu"'
Autor:
Linlin Wei, Ting Wang, Sisi Chen, Yeying Liu, Xueying Huang, Sujun Zheng, Bin Xu, Feng Ren, Mei Liu
Publikováno v:
Gut and Liver, Vol 17, Iss 5, Pp 795-805 (2023)
Background/Aims: To investigate the autoantibody against fumarate hydratase (FH), which is a specific liver failure-associated antigen (LFAA) and determine whether it can be used as a biomarker to evaluate the prognosis of acute-on-chronic liver fail
Externí odkaz:
https://doaj.org/article/c12ad2ac89894549865fd9822b147c9a
Autor:
Yeying Liu, Yuan Huang, Jie Ding, Nannan Liu, Shuang Peng, Jiangang Wang, Feng Wang, Yingjie Zhang
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Colon cancer is one of the three common malignant tumors, with lower 5 years survival rate. Akt is an important therapeutic target, while SC66 is a novel allosteric AKT inhibitor, which enhances the therapeutic effect in several t
Externí odkaz:
https://doaj.org/article/d4ef1b0313554b11a0087654d1369e4c
Autor:
Linlin Wei, Ting Wang, Sisi Chen, Yeying Liu, Xueying Huang, Sujun Zheng, Bin Xu, Feng Ren, Mei Liu
Publikováno v:
Gut and Liver.
To investigate the autoantibody against fumarate hydratase (FH), which is a specific liver failure-associated antigen (LFAA) and determine whether it can be used as a biomarker to evaluate the prognosis of acute-on-chronic liver failure (ACLF).An imm
Autor:
Yue Ao, Yingjie Zhang, Yi Hong, Lingling Zhang, Jie Ding, Jing Liu, Yuan Huang, Huanan Wang, Nannan Liu, Jiangang Wang, Lefeng Wang, Yeying Liu
Publikováno v:
Cancer Gene Therapy. 27:448-460
Colorectal cancer is the third most frequently diagnosed malignancies among both men and women, which has an increased mortality but a poor prognosis. Targeting mTOR becomes an effective approach that shows promising antitumor activities in various c
Autor:
Fei Luo, Yingjun Zhou, Jiangang Wang, Yuan Huang, Lingling Zhang, Xi Pan, Jingfei Chen, Yeying Liu, Shousong Cao, Juchang Zhong, Yingjie Zhang
Publikováno v:
Cancer Medicine
Purified vitexin compound 1 (VB1, a neolignan isolated and extracted from the seed of Chinese herb Vitex negundo) is an effective antitumor agent and exhibits promising clinical activity against various cancers including colorectal cancer. However, i
Autor:
Lingling Zhang, Yeying Liu, Guang Luo, Shuaiyu Long, Jing Liu, Nannan Liu, Chuchu Zhang, Yuan Huang, Yingjie Zhang
Publikováno v:
Cell Cycle
P53 is a critical tumor suppressor gene, activating p53 and its downstream targets to induce apoptosis is a promising way for cancer therapy. However, more than 50% of cancer patients have p53 mutations, which may cause cancer therapy resistance, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e84579245f05f821e01607b66434c578
https://europepmc.org/articles/PMC6927701/
https://europepmc.org/articles/PMC6927701/
Autor:
Huanan, Wang, Yeying, Liu, Jie, Ding, Yuan, Huang, Jing, Liu, Nannan, Liu, Yue, Ao, Yi, Hong, Lefeng, Wang, Lingling, Zhang, Jiangang, Wang, Yingjie, Zhang
Publikováno v:
Cancer gene therapy. 27(6)
Colorectal cancer is the third most frequently diagnosed malignancies among both men and women, which has an increased mortality but a poor prognosis. Targeting mTOR becomes an effective approach that shows promising antitumor activities in various c
Autor:
Jiangang Wang, Yingjie Zhang, Jie Ding, Yeying Liu, Yuan Huang, Nannan Liu, Feng Wang, Shuang Peng
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Background Colon cancer is one of the three common malignant tumors, with lower 5 years survival rate. Akt is an important therapeutic target, while SC66 is a novel allosteric AKT inhibitor, which enhances the therapeutic effect in several types of c
Autor:
Yeying Liu, Yujie Zhao, Lingling Zhang, Feng Wang, Yingjie Zhang, Li Sun, Xiaoxiao He, Yuan Huang
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Colon cancer is one of the three common malignant tumors, with a lower survival rate. Ipatasertib, a novel highly selective ATP-competitive pan-Akt inhibitor, shows a strong antitumor effect in a variety of carcinoma, including colon cancer. However,
Autor:
Xiaorong Dun, Yeying Liu
Publikováno v:
E3S Web of Conferences, Vol 179, p 02073 (2020)
In view of the fact that existing office chairs cannot fully meet the needs of office workers, especially the design of some adjustable parts, there is a lack of consideration for female size, body structure, and psychological needs. In this paper, t